10:38 AM
Sep 26, 2018
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Cervical cancer; lung cancer; ovarian cancer

Patient sample, cell culture and mouse studies suggest promoting ATP5H expression or inhibiting reactive oxygen species (ROS) could help treat therapy-resistant cancers. In tumor samples from patients with cervical cancer, low ATP5H levels were associated with advanced disease, poor response to combined chemo- and radiotherapy, and poor survival. In a human cervical cancer...

Read the full 273 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >